309 related articles for article (PubMed ID: 19435902)
21. Mangifera indica L. extract protects T cells from activation-induced cell death.
Hernández P; Delgado R; Walczak H
Int Immunopharmacol; 2006 Sep; 6(9):1496-505. PubMed ID: 16846844
[TBL] [Abstract][Full Text] [Related]
22. Up-regulation of c-FLIPshort and reduction of activation-induced cell death in T-cells from patients with Type 1 diabetes.
Richiusa P; Pizzolanti G; Misiano G; Mattina A; Citarrella R; Galluzzo A; Giordano C
Diabetes Nutr Metab; 2004 Feb; 17(1):6-11. PubMed ID: 15163118
[TBL] [Abstract][Full Text] [Related]
23. In vitro generated human memory-like T cells are CD95 type II cells and resistant towards CD95-mediated apoptosis.
Fas SC; Baumann S; Krueger A; Frey CR; Schulze-Bergkamen H; Brenner D; Stumpf C; Kappes K; Krammer PH
Eur J Immunol; 2006 Nov; 36(11):2894-903. PubMed ID: 17048269
[TBL] [Abstract][Full Text] [Related]
24. Low FAS/CD95 expression by CTCL correlates with reduced sensitivity to apoptosis that can be restored by FAS upregulation.
Wu J; Nihal M; Siddiqui J; Vonderheid EC; Wood GS
J Invest Dermatol; 2009 May; 129(5):1165-73. PubMed ID: 18923451
[TBL] [Abstract][Full Text] [Related]
25. Differential regulation of activation-induced cell death in individual human T cell clones.
Janssen O; Stocker A; Sanzenbacher R; Oberg HH; Siddiqi MA; Kabelitz D
Int Arch Allergy Immunol; 2000 Mar; 121(3):183-93. PubMed ID: 10729776
[TBL] [Abstract][Full Text] [Related]
26. TCR-mediated activation promotes GITR upregulation in T cells and resistance to glucocorticoid-induced death.
Zhan Y; Funda DP; Every AL; Fundova P; Purton JF; Liddicoat DR; Cole TJ; Godfrey DI; Brady JL; Mannering SI; Harrison LC; Lew AM
Int Immunol; 2004 Sep; 16(9):1315-21. PubMed ID: 15262900
[TBL] [Abstract][Full Text] [Related]
27. CD158 receptor controls cytotoxic T-lymphocyte susceptibility to tumor-mediated activation-induced cell death by interfering with Fas signaling.
Gati A; Guerra N; Gaudin C; Da Rocha S; Escudier B; Lécluse Y; Bettaieb A; Chouaib S; Caignard A
Cancer Res; 2003 Nov; 63(21):7475-82. PubMed ID: 14612548
[TBL] [Abstract][Full Text] [Related]
28. Specific resistance of T cells to CD95-induced apoptosis during S phase of the cell cycle.
Dao T; Huleatt JW; Hingorani R; Crispe IN
J Immunol; 1997 Nov; 159(9):4261-7. PubMed ID: 9379021
[TBL] [Abstract][Full Text] [Related]
29. Immunization with autologous T cells enhances in vivo anti-tumor immune responses accompanied by up-regulation of GADD45beta.
Wang L; Du F; Cao Q; Sheng H; Shen B; Zhang Y; Diao Y; Zhang J; Li N
Cell Res; 2006 Aug; 16(8):702-12. PubMed ID: 16826163
[TBL] [Abstract][Full Text] [Related]
30. A novel role for sphingolipid intermediates in activation-induced cell death in T cells.
Solomon JC; Sharma K; Wei LX; Fujita T; Shi YF
Cell Death Differ; 2003 Feb; 10(2):193-202. PubMed ID: 12700647
[TBL] [Abstract][Full Text] [Related]
31. Pentoxifylline induces apoptosis in vitro in cutaneous T cell lymphoma (HuT-78) and enhances FasL mediated killing by upregulating Fas expression.
Rishi L; Gahlot S; Kathania M; Majumdar S
Biochem Pharmacol; 2009 Jan; 77(1):30-45. PubMed ID: 18851957
[TBL] [Abstract][Full Text] [Related]
32. Activation-induced cell death in T cells and autoimmunity.
Zhang J; Xu X; Liu Y
Cell Mol Immunol; 2004 Jun; 1(3):186-92. PubMed ID: 16219166
[TBL] [Abstract][Full Text] [Related]
33. Increased activation-induced cell death of high IFN-gamma-producing T(H)1 cells as a mechanism of T(H)2 predominance in atopic diseases.
Akkoc T; de Koning PJ; Rückert B; Barlan I; Akdis M; Akdis CA
J Allergy Clin Immunol; 2008 Mar; 121(3):652-658.e1. PubMed ID: 18328893
[TBL] [Abstract][Full Text] [Related]
34. Differential role of tyrosine phosphorylation in the induction of apoptosis in T cell clones via CD95 or the TCR/CD3-complex.
Oberg HH; Lengl-Janssen B; Robertson MJ; Kabelitz D; Janssen O
Cell Death Differ; 1997 Jul; 4(5):403-12. PubMed ID: 16465259
[TBL] [Abstract][Full Text] [Related]
35. Frequent mutations of Fas gene in nasal NK/T cell lymphoma.
Takakuwa T; Dong Z; Nakatsuka S; Kojya S; Harabuchi Y; Yang WI; Nagata S; Aozasa K
Oncogene; 2002 Jul; 21(30):4702-5. PubMed ID: 12096347
[TBL] [Abstract][Full Text] [Related]
36. Blood stage malaria antigens induce different activation-induced cell death programs in splenic CD4+T cells.
Mukherjee P; Devi YS; Chauhan VS
Parasite Immunol; 2008 Oct; 30(10):497-514. PubMed ID: 18643960
[TBL] [Abstract][Full Text] [Related]
37. Fas/FasL-independent activation-induced cell death of T lymphocytes from HIV-infected individuals occurs without DNA fragmentation.
Kottilil S; Bowmer MI; Trahey J; Howley C; Gamberg J; Grant MD
Cell Immunol; 2001 Nov; 214(1):1-11. PubMed ID: 11902824
[TBL] [Abstract][Full Text] [Related]
38. Impaired apoptosis and immune senescence - cause or effect?
Hsu HC; Scott DK; Mountz JD
Immunol Rev; 2005 Jun; 205():130-46. PubMed ID: 15882350
[TBL] [Abstract][Full Text] [Related]
39. CD95 ligand mediates T-cell receptor-induced apoptosis of a CD4+ CD8+ double positive thymic lymphoma.
Schmitz I; Meyer C; Schulze-Osthoff K
Oncogene; 2006 Dec; 25(58):7587-96. PubMed ID: 16767155
[TBL] [Abstract][Full Text] [Related]
40. Human mesenchymal stem cells promote survival of T cells in a quiescent state.
Benvenuto F; Ferrari S; Gerdoni E; Gualandi F; Frassoni F; Pistoia V; Mancardi G; Uccelli A
Stem Cells; 2007 Jul; 25(7):1753-60. PubMed ID: 17395776
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
